Marsha R. Mailick, PhD – Slide of the Week
Age Trajectories of FXTAS-type Symptoms Total score by FXTAS Family History and College Degree Attainment in FMR1 Premutation Carrier Women
June 5, 2026
Krishanu Saha, PhD – Slide of the Week
Editing measurements, microphysiological systems (such as organoids and organs-on-chips) and in vivo imaging techniques present a spectrum of information across different scales, from single nucleotides in vitro to the whole body in vivo.
May 18, 2026
Luigi Puglielli, MD, PhD – Slide of the Week
The endoplasmic reticulum acetylation machinery has emerged as a new branch of the larger endoplasmic reticulum quality control system.
May 1, 2026
Caroline A Niziolek, PhD – Slide of the Week
Young adult speakers can be induced to increase the acoustic contrast between vowels through exposure to a nonuniform auditory "centralization" feedback perturbation that makes vowels sound less distinct from one another.
April 17, 2026
Ruth Litovsky, PhD – Slide of the Week
We studied Cognitive load by measuring both speech understanding in noise and pupillometry (Pupil dilation).
April 1, 2026
Margarita Kaushanskaya, PhD – Slide of the Week
Children born preterm are at an elevated risk of language delays compared to children born full-term.
February 27, 2026
Katherine Hustad, PhD – Slide of the Week
Does the Use of Crowdsourced Listeners Yield Different Speech Intelligibility Results Than In-Person Listeners for Typically Developing Children?
February 13, 2026
Tracy L. Hagemann, PhD – Slide of the Week
Alexander disease (AxD) is a rare neurological disorder caused by dominant gain-of-function mutations in the gene for glial acidic fibrillary protein (GFAP).
January 26, 2026
Ido Haber & Aviad Hai, PhD – Slide of the Week
TI-Toolbox: An Open-Source Software for Temporal Interference Stimulation Research
January 9, 2026
Austin Pier & Ngawang Namru (Gomez Laboratory) – Slide of the Week
Tuberous Sclerosis Complex (TSC) is an autosomal dominant neurodevelopmental disorder caused by a monogenic mutation to either TSC1 or TSC2. Nearly one-half of TSC patients have mild to profound intellectual disabilities and autism, with the majority developing seizures and neuropsychiatric conditions.
December 15, 2025- More Slide of the Week posts
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.